Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer ...
In a study of men on active surveillance for localized prostate cancer, each 1-unit increase in Mediterranean diet score, calculated based on patients’ baseline food frequency questionnaire ...
PSA blood test Compared with absolute PSA, PSA velocity associated more with increased likelihood of progression among men on active surveillance for prostate cancer. PSA velocity (PSAV) is associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback